GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.

Contributed by: Business Wire

Logo

Business Wire logo

Images

SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products
SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products
Business Wire embedded0

Tags

Research
Medical Devices
Health Technology
Biotechnology
Radiology
Health
Pharmaceutical
Other Science
Science
SOFIE Biosciences

More Like This

Illustrative example: cancer associated fibroblasts (CAFs) and the tumor microenvironment. (Photo: Business Wire)

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

Nihon Medi-Physics headquarters and woman looking at molecular imaging images (Photo: Business Wire)

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

Nihon Medi-Physics headquarters and radiopharmaceutical imaging agents about to go through labelling and packing process.

GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan

Business Wire logo

Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China

Business Wire logo

GE HealthCare announces CE Mark for the Omni 128cm total body PET/CT system

PR Newswire associated0

Positrigo Secures CE Mark in Europe for its Pioneering Dedicated Brain PET System

Business Wire logo

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

FAMAR Group announces contract manufacturing agreement with GE HealthCare